GlaxoSmithKline Biologicals
ActiveSummary
GlaxoSmithKline Biologicals has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9.98B and a net result of €2.40B. Equity is shrinking by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 65% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
70
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability90▲+1
Solvency81▼-17
Growth57▼-2
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity tight (current ratio 1.47 against 2.59 in 2024; short-term debt: 40.1% and cash: 0% of total assets), and 44.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.9%
Return on assets
13.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
31 d early
2024
29 d early
2023
2 d early
2022
25 d early
2021
11 d early
2020
16 d early
2019
1 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema, statutory accounts
Turnover
€7.44B▼ 5.4%
2024 · €7.87B
2018: €4.69B
2019: €6.79B
2020: €6.47B
2021: €4.92B
2022: €7.16B
2023: €8.86B
2024: €7.87B
2018 → 2025
EBIT margin
35.2%▲ 6.6pp
2024 · 28.6%
2018: 11.3%
2019: 32.2%
2020: 27.9%
2021: 8.8%
2022: 26.9%
2023: 36.2%
2024: 28.6%
2018 → 2025
Net result
€2.40B▲ 9.3%
2024 · €2.19B
2018: €515.22M
2019: €1.99B
2020: €1.78B
2021: €455.64M
2022: €1.94B
2023: €3.17B
2024: €2.19B
2018 → 2025
Working capital
€3.38B▼ 48.8%
2024 · €6.60B
2018: €9.27B
2019: €11.44B
2020: €12.06B
2021: €7.15B
2022: €8.50B
2023: €11.32B
2024: €6.60B
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€4.92B-€7.16B▲ 45.6%€8.86B▲ 23.7%€7.87B▼ 11.2%€7.44B▼ 5.4%
Equity€12.99B-€14.61B▲ 12.5%€17.68B▲ 21.0%€13.29B▼ 24.8%€9.98B▼ 24.9%
Operating result€431.95M-€1.93B▲ 346%€3.21B▲ 66.5%€2.25B▼ 29.7%€2.62B▲ 16.4%
Net result€455.64M-€1.94B▲ 326%€3.17B▲ 63.3%€2.19B▼ 30.9%€2.40B▲ 9.3%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 16% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €17.83B
Fixed assets
€7.30B ▼ 0.9%
Current assets
€10.53B ▼ 1.9%
Equity and liabilities €17.83B
Equity
€9.98B ▼ 24.9%
Provisions
€616.89M ▲ 3.8%
Debt
€7.24B ▲ 71.8%
Debt's share of the balance-sheet total rises from 23.3% to 40.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€4.34B▲
2024 · €4.01B
Cash flow
€4.12B▲
2024 · €3.95B
Current ratio
1.47▼
2024 · 2.59
Quick ratio
1.06▼
2024 · 1.85
Debt to equity
0.73▲
2024 · 0.32
ROE
24.0%▲
2024 · 16.5%
ROA
13.4%▲
2024 · 12.1%
Interest coverage
2770.61▲
2024 · 1329.62
Debt ≤ 1 year
€7.16B▲
2024 · €4.14B
Debt > 1 year
€35.70M▼
2024 · €39.78M
Income taxes
€339.57M▲
2024 · €308.13M
Staff costs
€1.29B▼
2024 · €1.32B
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 102 lines
Balance sheet
Code20242025
Assets
Total assets20/58€18.10B€17.83B▼
Formation expenses20€0€0=
Fixed assets21/28€7.37B€7.30B▼
Intangible fixed assets21€3.08B€3.01B▼
Tangible fixed assets22/27€2.10B€2.10B▲
Land and buildings22€1.07B€1.19B▲
Plant, machinery and equipment23€213.32M€214.91M▲
Furniture and vehicles24€53.74M€60.51M▲
Leasing and similar rights25€44.81M€40.24M▼
Assets under construction and advance payments27€721.94M€598.53M▼
Financial fixed assets28€2.19B€2.19B=
Affiliated companies280/1€1.90B€1.90B=
Participating interests280€1.90B€1.90B=
Companies linked by participating interests282/3€282.29M€282.29M=
Participating interests282€282.29M€282.29M=
Other financial fixed assets284/8€246k€246k=
Shares284€246k€246k=
Current assets29/58€10.73B€10.53B▼
Stocks and contracts in progress3€3.10B€2.98B▼
Stocks30/36€3.10B€2.98B▼
Raw materials and consumables30/31€317.09M€295.37M▼
Work in progress32€2.35B€2.38B▲
Finished goods33€430.67M€302.30M▼
Amounts receivable within one year40/41€985.10M€823.27M▼
Trade receivables40€291.02M€191.35M▼
Other amounts receivable41€694.08M€631.92M▼
Current investments50/53€6.60B€6.68B▲
Other investments51/53€6.60B€6.68B▲
Cash at bank and in hand54/58€15.35M€22k▼
Deferred charges and accrued income490/1€36.94M€50.62M▲
Equity and liabilities
Total equity and liabilities10/49€18.10B€17.83B▼
Equity10/15€13.29B€9.98B▼
Contributions10/11€8.38B€8.38B=
Capital10€8.38B€8.38B=
Issued capital100€8.38B€8.38B=
Reserves13€4.91B€1.60B▼
Non-distributable reserves130/1€837.96M€837.96M=
Legal reserve130€837.96M€837.96M=
Distributable reserves133€4.07B€758.54M▼
Provisions and deferred taxes16€594.36M€616.89M▲
Provisions for liabilities and charges160/5€594.36M€616.89M▲
Pensions and similar obligations160€484.51M€480.15M▼
Major repairs and maintenance162€43.20M€45.62M▲
Other liabilities and charges164/5€66.64M€91.12M▲
Amounts payable17/49€4.21B€7.24B▲
Amounts payable after more than one year17€39.78M€35.70M▼
Financial debts170/4€39.78M€35.70M▼
Leasing and similar obligations172€39.78M€35.70M▼
Amounts payable within one year42/48€4.14B€7.16B▲
Current portion of amounts payable after more than one year42€3.94M€4.09M▲
Financial debts43-€191k
Other loans439-€191k
Trade debts44€1.11B€1.00B▼
Suppliers440/4€1.11B€1.00B▼
Taxes, remuneration and social security45€361.80M€367.46M▲
Taxes450/3€12.87M€41.65M▲
Remuneration and social security454/9€348.93M€325.81M▼
Other amounts payable47/48€2.66B€5.78B▲
Accrued charges and deferred income492/3€38.83M€46.26M▲
Income statement
Code20242025
Operating income70/76A€9.71B€9.72B▲
Turnover70€7.87B€7.44B▼
Change in stocks of work in progress, finished goods and contracts in progress71€52.84M€28.60M▼
Own construction capitalised72€1.48B€1.38B▼
Other operating income74€312.03M€435.66M▲
Non-recurring operating income76A€3.30M€434.66M▲
Operating charges60/66A€7.46B€7.10B▼
Goods for resale, raw materials and consumables60€591.96M€460.53M▼
Purchases600/8€499.39M€438.82M▼
Change in stocks: decrease (increase)609€92.57M€21.71M▼
Services and other goods61€3.59B€3.34B▼
Remuneration, social security and pensions62€1.32B€1.29B▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.76B€1.72B▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-61.94M€122.80M▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€-98.94M€-4.37M▲
Other operating charges640/8€19.79M€21.87M▲
Non-recurring operating charges66A€337.67M€144.57M▼
Operating profit (loss)9901€2.25B€2.62B▲
Financial income75/76B€358.18M€281.91M▼
Recurring financial income75€358.18M€281.91M▼
Income from financial fixed assets750€14.23M€0▼
Income from current assets751€248.18M€149.42M▼
Other financial income752/9€95.77M€132.49M▲
Financial charges65/66B€109.13M€166.65M▲
Recurring financial charges65€109.13M€166.65M▲
Debt charges650€3.02M€1.57M▼
Other financial charges652/9€106.11M€165.08M▲
Non-recurring financial charges66B€0-
Profit (loss) for the period before taxes9903€2.50B€2.74B▲
Income taxes67/77€308.13M€339.57M▲
Taxes670/3€361.71M€378.40M▲
Tax adjustments and reversals of tax provisions77€53.58M€38.84M▼
Profit (loss) for the period9904€2.19B€2.40B▲
Profit (loss) for the period to be appropriated9905€2.19B€2.40B▲
Appropriation of the result
Profit (loss) to be appropriated9906€2.19B€2.40B▲
Transfer from equity791/2€4.40B€3.32B▼
From reserves792€4.40B€3.32B▼
Transfer to equity691/2€7.55M€0▼
To the legal reserve6920€7.55M€0▼
To other reserves6921€0-
Profit to be distributed694/7€6.58B€5.71B▼
Return on contributions (dividend)694€6.58B€5.71B▼
Social balance
Average headcount (FTE)90878,681.28,371.0▼
The notes to these accounts (141 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
State Gazette act
Resignations: E. Amory (director) and J. Louahed (director)Appointments: C. Noirhomme, D. Descamps and Deloitte Réviseurs d'Entreprises · Reappointments: I. Rapilly, C. Noirhomme and 6 others · Permanent representative: Koen Neijens18 facts ▸
State Gazette act
Resignations: E. Amory (director) and J. Louahed (director)
Appointments: C. Noirhomme, D. Descamps and Deloitte Réviseurs d'Entreprises · Reappointments: I. Rapilly, C. Noirhomme and 6 others · Permanent representative: Koen Neijens18 facts ▸
- General meeting, 24/06/2026
- Director resignation, E. Amory (director)
- Director resignation, J. Louahed (director)
- Director appointment, C. Noirhomme (director)
- Director appointment, D. Descamps (director)
- Director reappointment, I. Rapilly (director)
- Director reappointment, C. Noirhomme (director)
- Director reappointment, D. Descamps (director)
- Director reappointment, A. Van Goethem (director)
- Director reappointment, R. Simard (director)
- Director reappointment, B. Alsteens (director)
- Director reappointment, E. Felix (director)
- +6 further facts in this act
14-07
State Gazette act
Resignations & appointmentsAccounting effect · Power of attorney5 facts ▸
State Gazette act
Resignations & appointments
Accounting effect · Power of attorney5 facts ▸
- Board meeting, 11/05/2026
- Accounting effect, 01/07/2026
- Power of attorney, Emmanuel Félix
- Power of attorney, Philippe Denoël
- Power of attorney, Alberto Giummarra
10-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · consolidated
2025
05-11
State Gazette act
Resignation: Emmanuel Amory (director and managing director)Appointments: Christelle Noirhomme, Emmanuel Felix and Jamila Louahed · Power of attorney6 facts ▸
State Gazette act
Resignation: Emmanuel Amory (director and managing director)
Appointments: Christelle Noirhomme, Emmanuel Felix and Jamila Louahed · Power of attorney6 facts ▸
- Board meeting, 02/09/2025
- Director resignation, Emmanuel Amory (director and managing director)
- Director appointment, Christelle Noirhomme (director)
- Director appointment, Emmanuel Felix (managing director)
- Director appointment, Jamila Louahed (managing director)
- Power of attorney, Christelle Noirhomme
03-09
State Gazette act
Resignations: Irène Rapilly, Jamila Louahed and 5 othersReappointments: Irène Rapilly, Jamila Louahed and 5 others · Appointments: Emmanuel Félix (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Gert Vanhees and Neijens20 facts ▸
State Gazette act
Resignations: Irène Rapilly, Jamila Louahed and 5 others
Reappointments: Irène Rapilly, Jamila Louahed and 5 others · Appointments: Emmanuel Félix (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Gert Vanhees and Neijens20 facts ▸
- General meeting, 25/06/2025
- Director resignation, Irène Rapilly (director)
- Director resignation, Jamila Louahed (director)
- Director resignation, Aglaé Van Goethem (director)
- Director resignation, Regis Simard (director)
- Director resignation, Emmanuel Amory (director)
- Director resignation, Benoit Alsteens (director)
- Director resignation, Pascal Legraive (director)
- Director reappointment, Irène Rapilly (director)
- Director reappointment, Jamila Louahed (director)
- Director reappointment, Aglaé Van Goethem (director)
- Director reappointment, Regis Simard (director)
- +8 further facts in this act
30-07
State Gazette act
Permanent representative: Emmanuel AmoryAccounting effect · Power of attorney7 facts ▸
State Gazette act
Permanent representative: Emmanuel Amory
Accounting effect · Power of attorney7 facts ▸
- Board meeting, 13/05/2025
- Accounting effect, 01/07/2025
- Power of attorney, Emmanuel Amory
- Power of attorney, Philippe Denoel
- Power of attorney, Cristelle Noirhomme
- Power of attorney, Nathalie Houssein
- Permanent representative, Emmanuel Amory
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
05-08
State Gazette act
Resignation: Antoon Loomans (director)Appointments: Aglaé Van Goethem (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Reappointments: Irène Rapilly, Jamila Louahed and 5 others · Mandate compensation12 facts ▸
State Gazette act
Resignation: Antoon Loomans (director)
Appointments: Aglaé Van Goethem (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Reappointments: Irène Rapilly, Jamila Louahed and 5 others · Mandate compensation12 facts ▸
- General meeting, 26/06/2024
- Director resignation, Antoon Loomans (director)
- Director appointment, Aglaé Van Goethem (director)
- Director reappointment, Irène Rapilly (director)
- Director reappointment, Jamila Louahed (director)
- Director reappointment, Aglaé Van Goethem (director)
- Director reappointment, Regis Simard (director)
- Director reappointment, Emmanuel Amory (director)
- Director reappointment, Benoit Alsteens (director)
- Director reappointment, Pascal Legraive (director)
- Mandate compensation, GlaxoSmithKline Biologicals SA
- Auditor appointment, Deloitte Réviseurs d'Entreprises (statutory auditor)
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
07-02
State Gazette act
Resignation: Antoon Loomans (director)Appointment: Aglaé Van Goethem (director)3 facts ▸
State Gazette act
Resignation: Antoon Loomans (director)
Appointment: Aglaé Van Goethem (director)3 facts ▸
- Board meeting, 22/11/2023
- Director resignation, Antoon Loomans (director)
- Director appointment, Aglaé Van Goethem (director)
2023
31-12
Financial
Highest result since 2018net €3.17B ▲63.3%
Operating result €3.21B, net result €3.17B, both a record.
Show earlier events
03-11
State Gazette act
Resignation: Antoon LOOMANS (director)1 fact ▸
State Gazette act
Resignation: Antoon LOOMANS (director)
1 fact ▸
- Director resignation, Antoon LOOMANS (director)
23-08
State Gazette act
Reappointments: Irène Rapilly, Jamila Louahed and 5 othersMandate compensation · Auditor mandate expiry · Auditor fees11 facts ▸
State Gazette act
Reappointments: Irène Rapilly, Jamila Louahed and 5 others
Mandate compensation · Auditor mandate expiry · Auditor fees11 facts ▸
- General meeting, 28/06/2023
- Director reappointment, Irène Rapilly (director)
- Director reappointment, Jamila Louahed (director)
- Director reappointment, Regis Simard (director)
- Director reappointment, Emmanuel Amory (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Benoit Alsteens (director)
- Director reappointment, Pascal Legraive (director)
- Mandate compensation, GlaxoSmithKline Biologicals SA
- Auditor mandate expiry, commissaire, Le mandat de commissaire ... expire ... et ne doit donc pas être renouvelé cette année.
- Auditor fees, EUR 1.500.000 (hors TVA, débours divers et cotisation IRE)
14-07
State Gazette act
Permanent representative: Emmanuel AmoryAccounting effect · Power of attorney16 facts ▸
State Gazette act
Permanent representative: Emmanuel Amory
Accounting effect · Power of attorney16 facts ▸
- Board meeting, 05/05/2023
- Accounting effect, 03/07/2023
- Power of attorney, Emmanuel Amory
- Power of attorney, Philippe Denoel
- Power of attorney, Philippe Denoel
- Power of attorney, Philippe Denoel
- Power of attorney, Philippe Denoel
- Power of attorney, Philippe Denoel
- Power of attorney, Cristelle Noirhomme
- Power of attorney, Cristelle Noirhomme
- Power of attorney, Cristelle Noirhomme
- Power of attorney, Cristelle Noirhomme
- +4 further facts in this act
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
24-03
State Gazette act
Resignations & appointmentsPower of attorney16 facts ▸
State Gazette act
Resignations & appointments
Power of attorney16 facts ▸
- Board meeting, 01/03/2023
- Power of attorney, e3, e4, e5, e6, e7, e8, e9, e10, e11, e12, e13, e14, e15, e16, e17, e18, e19, e20, e21, e22, e23, e24, e25, e26, e27
- Power of attorney, e3, e4, e5, e6, e7
- Power of attorney, e8, e9, e10, e11, e12, e13, e14, e15
- Power of attorney, e16, e17
- Power of attorney, e16, e17
- Power of attorney, e8, e18
- Power of attorney, e8, e9, e10, e11, e14, e12, e15, e13
- Power of attorney, e8, e9, e12, e10, e13, e11, e14
- Power of attorney, deux administrateurs
- Power of attorney, e9, e10, e11, e14, e13
- Power of attorney, e9, e21, e10, e11, e22, e23, e14, e13, e24
- +4 further facts in this act
23-03
State Gazette act
Resignation: Gabriel MILLAN (director)Power of attorney2 facts ▸
State Gazette act
Resignation: Gabriel MILLAN (director)
Power of attorney2 facts ▸
- Director resignation, Gabriel MILLAN (director)
- Power of attorney, Gabriel MILLAN
14-02
State Gazette act
Resignation: Roger Connor (director)Appointments: Regis Simard, Benoît Alsteens and 2 others · Mandate compensation7 facts ▸
State Gazette act
Resignation: Roger Connor (director)
Appointments: Regis Simard, Benoît Alsteens and 2 others · Mandate compensation7 facts ▸
- General meeting, 10-01-2023
- Director resignation, Roger Connor (director)
- Director appointment, Regis Simard (director)
- Director appointment, Benoît Alsteens (director)
- Director appointment, Pascal Legraive (director)
- Director appointment, Jamila Louahed (director)
- Mandate compensation, GlaxoSmithKline Biologicals
2022
31-12
Financial
Liquidity triplescurrent ratio 5.72
Current ratio from 2.09 to 5.72; short-term debt falls from €6.56B to €1.80B.
01-08
State Gazette act
Resignation: P. Florent (director)Reappointments: Roger Connor, Emmanuel Amory and 3 others · Appointment: Deloitte Réviseurs d'Entreprises (statutory auditor) · Mandate compensation10 facts ▸
State Gazette act
Resignation: P. Florent (director)
Reappointments: Roger Connor, Emmanuel Amory and 3 others · Appointment: Deloitte Réviseurs d'Entreprises (statutory auditor) · Mandate compensation10 facts ▸
- General meeting, 22/06/2022
- Director resignation, P. Florent (director)
- Director reappointment, Roger Connor (director)
- Director reappointment, Emmanuel Amory (director)
- Director reappointment, Gabriel Millan (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Irène Rapilly (director)
- Mandate compensation, GlaxoSmithKline Biologicals SA
- Auditor appointment, Deloitte Réviseurs d'Entreprises (statutory auditor)
- Auditor fees, 2022, EUR 1.425.000
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
11-07
State Gazette act
Resignation: Patrick Florent (director)Appointment: Emmanuel Amory (managing director) · Mandate compensation5 facts ▸
State Gazette act
Resignation: Patrick Florent (director)
Appointment: Emmanuel Amory (managing director) · Mandate compensation5 facts ▸
- General meeting, 06/05/2022
- Director resignation, Patrick Florent (director)
- Director resignation, Patrick Florent (managing director)
- Director appointment, Emmanuel Amory (managing director)
- Mandate compensation, Emmanuel Amory
11-07
State Gazette act
Resignations & appointmentsBoard meeting1 fact ▸
State Gazette act
Resignations & appointments
Board meeting1 fact ▸
- Board meeting, 6 mai 2022
02-06
State Gazette act
Appointment: Emmanuel Amory (director)Mandate compensation3 facts ▸
State Gazette act
Appointment: Emmanuel Amory (director)
Mandate compensation3 facts ▸
- General meeting, 22/04/2022
- Director appointment, Emmanuel Amory (director)
- Mandate compensation, GlaxoSmithKline Biologicals
23-02
State Gazette act
Appointments: Patrick Florent, Philippe Denoel and Cristelle NoirhommeAccounting effect · Power of attorney14 facts ▸
State Gazette act
Appointments: Patrick Florent, Philippe Denoel and Cristelle Noirhomme
Accounting effect · Power of attorney14 facts ▸
- Board meeting, 06/12/2021
- Accounting effect, 01/02/2022
- Director appointment, Patrick Florent (daily management delegate)
- Director appointment, Philippe Denoel (director)
- Director appointment, Philippe Denoel (director)
- Director appointment, Philippe Denoel (director)
- Director appointment, Philippe Denoel (président du conseil de gouvernance)
- Director appointment, Philippe Denoel (director)
- Director appointment, Cristelle Noirhomme (director)
- Director appointment, Cristelle Noirhomme (director)
- Director appointment, Cristelle Noirhomme (director)
- Director appointment, Cristelle Noirhomme (director)
- +2 further facts in this act
2021
31-12
Financial
Weakest financial yearnet €455.64M ▼74.4%
Net result drops to €455.64M, the lowest in the series; recovery starts the following year.
24-12
State Gazette act
Capital & shares · Statutes amendmentCapital decrease · Capital · Statutes amendment4 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital decrease · Capital · Statutes amendment4 facts ▸
- General meeting, 16 décembre 2021
- Capital decrease, €5.100.000.000
- Capital, €8.379.632.620,82
- Statutes amendment
30-07
State Gazette act
Resignations: Gunther Koch, Roger Connor and 3 othersReappointments: Roger Connor, Patrick Florent and 2 others · Appointments: Irène Rapilly (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Mandate compensation13 facts ▸
State Gazette act
Resignations: Gunther Koch, Roger Connor and 3 others
Reappointments: Roger Connor, Patrick Florent and 2 others · Appointments: Irène Rapilly (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Mandate compensation13 facts ▸
- General meeting, 23/06/2021
- Director resignation, Gunther Koch (director)
- Director resignation, Roger Connor (director)
- Director resignation, Patrick Florent (director)
- Director resignation, Antoon Loomans (director)
- Director resignation, E. Hanon (director)
- Director reappointment, Roger Connor (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Gabriel Millan (director)
- Director appointment, Irène Rapilly (director)
- Mandate compensation, GlaxoSmithKline Biologicals SA
- +1 further facts in this act
30-07
State Gazette act
Resignations & appointmentsPower of attorney12 facts ▸
State Gazette act
Resignations & appointments
Power of attorney12 facts ▸
- Board meeting, 06/05/2021
- Power of attorney, Patrick Florent (day-to-day manager)
- Power of attorney, Antigoni Alexandrou
- Power of attorney, Anna Maria Walkowiak-Kamińska
- Power of attorney, Beata Anna Szyszkowska
- Power of attorney, Astrid Luciane
- Power of attorney, Jacek Mironczuk
- Power of attorney, Gabriel Millan
- Power of attorney, Daniel Beumier
- Power of attorney, Vincent Willemant
- Power of attorney, Carine Abras
- Power of attorney, Barbara Vinken
15-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
10-02
State Gazette act
Resignations & appointmentsPower of attorney1 fact ▸
State Gazette act
Resignations & appointments
Power of attorney1 fact ▸
- Power of attorney, Daniel BEUMIER
2020
13-10
State Gazette act
Permanent representatives: Gert Vanhees and Eric NysAccounting effect · Mandate term4 facts ▸
State Gazette act
Permanent representatives: Gert Vanhees and Eric Nys
Accounting effect · Mandate term4 facts ▸
- Permanent representative, Gert Vanhees
- Permanent representative, Eric Nys
- Accounting effect, 01/01/2020
- Mandate term, jusqu'à l'issue de l'assemblée générale qui se prononcera sur les comptes annuels clos au 31 décembre 2020
17-08
State Gazette act
Resignations: Jay Green (director) and Deloitte Réviseurs d'Entreprises (statutory auditor)Reappointments: Roger Connor, Patrick Florent and 3 others · Appointment: Gabriel Millan (director) · Mandate compensation11 facts ▸
State Gazette act
Resignations: Jay Green (director) and Deloitte Réviseurs d'Entreprises (statutory auditor)
Reappointments: Roger Connor, Patrick Florent and 3 others · Appointment: Gabriel Millan (director) · Mandate compensation11 facts ▸
- General meeting, 24/06/2020
- Director resignation, Jay Green (director)
- Director reappointment, Roger Connor (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Emmanuel Hanon (director)
- Director appointment, Gabriel Millan (director)
- Mandate compensation, GlaxoSmithKline Biologicals SA
- Auditor resignation, Deloitte Réviseurs d'Entreprises (statutory auditor)
- Auditor fees, EUR 1.300.000
30-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
17-07
State Gazette act
Resignations & appointmentsAccounting effect · Power of attorney21 facts ▸
State Gazette act
Resignations & appointments
Accounting effect · Power of attorney21 facts ▸
- Board meeting, 11/05/2020
- Accounting effect, 01/07/2020
- Power of attorney, Patrick Fiorent
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- Power of attorney, Gabriel Millan
- +9 further facts in this act
26-06
State Gazette act
Appointment: Patrick Florent (managing director)2 facts ▸
State Gazette act
Appointment: Patrick Florent (managing director)
2 facts ▸
- Board meeting, 18/11/2019
- Director appointment, Patrick Florent (managing director)
14-02
State Gazette act
Capital & sharesCapital increase · Capital · Statutes amendment5 facts ▸
State Gazette act
Capital & shares
Capital increase · Capital · Statutes amendment5 facts ▸
- General meeting, 30 janvier 2020
- Capital increase, €3.703.566.240
- Capital, €13.479.632.620,82
- Statutes amendment
- Reserve release, 3.703.566.240,00 EUR
2019
09-08
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 2 othersAppointments: Roger Connor, Emmanuel Hanon and Deloitte Réviseurs d'Entreprises · Mandate compensation9 facts ▸
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 2 others
Appointments: Roger Connor, Emmanuel Hanon and Deloitte Réviseurs d'Entreprises · Mandate compensation9 facts ▸
- General meeting, 26/06/2019
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Jay Green (director)
- Director appointment, Roger Connor (director)
- Director appointment, Emmanuel Hanon (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- Auditor appointment, Deloitte Réviseurs d'Entreprises (statutory auditor)
17-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
01-02
State Gazette act
Resignations & appointmentsAccounting effect · Power of attorney16 facts ▸
State Gazette act
Resignations & appointments
Accounting effect · Power of attorney16 facts ▸
- Board meeting, 19/11/2018
- Accounting effect, 15/01/2019
- Power of attorney, Philippe Denoel
- Power of attorney, Pascal Lizin
- Power of attorney, Jay Green, Denis Dubru, Michel Nevens, Jerry Stofferis, Vincent Willemant, Anne-Laure Castel, Isabelle Janssens, Carine Abras, Barbara Vinken, Deborah Puttemans, Alain Goossens, Frank Vandewal, Valérie Snauwaert, Christelle Flamme
- Power of attorney, Aurélie Widart, Marie Delecourt, Guillaume Eckes, Djiei Sarr, Patricia Callewaert, Thi Minh Thoa Tran, Kristell Houdement, Caroline Camy-Portenabe, Marie Schaegis, Alix Brodin, Isabelle Henry, Elise Lenclud, Andrea Fry, Samia Mohammedi, Mélodie Lemoine, Laura de Paz, Xavier Derouck, Christophe De Jaegher, Marcin Kierul, Alexandre Reumont, Jean-Philippe Dubuisson, Laurent De Busschere, Mathieu Crouzet, Vineet Garg, Maxence Deheunynck, Kevin Robert, Benedikt Lufua, Xavier Jungers, Philippe Mordier, Gregory Keteleer, Jean-Christophe Art, David Bernard, François Roux, Xavier Almeida Alvear, Brice Bouffard, Bénédicte de Moreau d'Andoy, Marylène Lombardi, Filomena Maria Brandao De Carvalho, Katia Taillard, Inma Lafuente, Frédéric Stagnitto, Laurent Chevallier, Mathieu Pascal, Yannick Vernaeve-Schoen, Bertrand Masselin
- Power of attorney, Catherine Ghislain, Loren Cooper, Claude Copin, Isabelle Janssens, Anne-Laure Castel, Barbara Philippe, Antoon Loomans, Jay Green, Denis Dubru, Roger Connor, Patrick Florent, John McGrath, Emmanuel Hanon, Andy Neefs, Jeroen De Vlam, Danielle Caucheteux, Christophe Pierret, Koen Quanten, Philippe Denoel, Pascal Lizin, Nathalie Houssein, Isabelle Sneessens, Sophie Wathour
- Power of attorney, Gunther Koch, Roger Connor, François Pirard, Carl Genard, Françoise Derep, Caroline Strobbe, Isabelle Leclercq, Alain Goossens, Frank Vandewal, Matthias Van Holm, Nathalie Houssein, Antoon Loomans, Catherine Ghislain
- Power of attorney, Patricia Pardon, Sandrine Nuytten, Pascal Reyntjens, Frédéric Anciaux, Marc Venot, Christophe Bertholet, Jonathan Collin, Denis Dubru, Marie Berranger, David Lechleiter, Régis Chantereau, Johan Matthijs, Roger Connor, Jay Green, Antoon Loomans, John McGrath, John Musunga, Marie Dernoncourt, Bruno Quoidbach, Carlos Morales, David Rea, Jean-Christophe May, Emmanuel Hanon, Thomas Breuer, Robin Duurland, Els Hauspie
- Power of attorney, Roger Connor, Jay Green, Antoon Loomans, Emmanuel Hanon, Catherine Ghislain, Loren Cooper, Christine Marie Vanderlinden, Sandrine Fontaine, Julie Vandekerckhove, Sarah Meredith, Ulrike Krause, David Rea
- Power of attorney, Cécile Barnich, Denis Lassance, Pascal Mettens, Marie-Thérèse Martin, Emmanuel Hanon, Jamila Louahed, Camelia Marcos, Pierfrancesca Ceddia, Thomas Breuer, Alberta Di Pasquale, Anil Dutta, Otavio Augusto Leite Cintra, Volker Walter Vetter, Bernard Joseph F. Hoet, Attila Geza Mihalyi, Jens Ulrich Stegmann, Tatjana Poplazarova, Virginie Hamiaux, Christine Vanderlinden, Dominique Lemoine, Alice Loper, Matthew Sanders, Koen De Heyder, Jean-Marc Wilkin, Apostolos Mamakis, Michel Stoffel, Stephen Cook, Philippe Denoel, Marguerite Deschamps, Jessica Kantorowicz, Valerie Malisse, Stephane Veeristra, Alain Brecx, Klaas Boone, Frédéric René Sallmann, Yannick Vanloubbeeck, Jean-François Toussaint, Dominique Descamps, Julian Bouchard, François Meurice
- Power of attorney, Michele Ghinizzini, Denis Beco, Olivier Vanloocke, Emmanuel Felix, Loren Cooper, Russell Thirsk, Emmanuel Amory, Scott McColm, Roger Connor, John McGrath, David Lechleiter
- +4 further facts in this act
01-02
State Gazette act
Resignation: Luc Debruyne (director)2 facts ▸
State Gazette act
Resignation: Luc Debruyne (director)
2 facts ▸
- Board meeting, 19/11/2018
- Director resignation, Luc Debruyne (director)
2018
11-09
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 6 othersAppointments: William Dawson (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Resignation: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation23 facts ▸
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 6 others
Appointments: William Dawson (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Resignation: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation23 facts ▸
- General meeting, 27/06/2018
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Luc Debruyne (director)
- Director reappointment, Jay Green (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Russell Edward Thirsk (director)
- Director reappointment, Jamila Louahed (director)
- Director appointment, William Dawson (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- Auditor resignation, PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor)
- +11 further facts in this act
01-08
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 6 othersAppointments: William Dawson (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Resignation: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation14 facts ▸
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 6 others
Appointments: William Dawson (director) and Deloitte Réviseurs d'Entreprises (statutory auditor) · Resignation: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation14 facts ▸
- General meeting, 28/06/2017
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Luc Debruyne (director)
- Director reappointment, Jay Green (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Russell Thirsk (director)
- Director reappointment, Jamila Louahed (director)
- Director appointment, William Dawson (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- Auditor appointment, Deloitte Réviseurs d'Entreprises
- +2 further facts in this act
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
09-01
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 07/12/2017
- Power of attorney, Denis Dubru
2017
03-08
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 7 othersAppointment: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation12 facts ▸
State Gazette act
Reappointments: Patrick Florent, Gunther Koch and 7 others
Appointment: PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation12 facts ▸
- General meeting, 28/06/2017
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Luc Debruyne (director)
- Director reappointment, Jay Green (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Russell Thirsk (director)
- Director reappointment, Jamila Louahed (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- Auditor appointment, PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor)
26-05
State Gazette act
Resignations & appointmentsAccounting effect · Power of attorney14 facts ▸
State Gazette act
Resignations & appointments
Accounting effect · Power of attorney14 facts ▸
- Board meeting, 27/04/2017
- Accounting effect, 15/05/2017
- Power of attorney, Philippe Denoel
- Power of attorney, Pascal Lizin
- Power of attorney, Marie Poncelet
- Power of attorney, Eric Sarlet
- Power of attorney, Paul van Hoof
- Power of attorney, Gisela Payeras
- Power of attorney, Andy Neefs
- Power of attorney, Jeroen De Vlam
- Power of attorney, Danielle Caucheteux
- Power of attorney, Pierre Mathot
- +2 further facts in this act
06-03
State Gazette act
Resignations & appointmentsAccounting effect · Power of attorney22 facts ▸
State Gazette act
Resignations & appointments
Accounting effect · Power of attorney22 facts ▸
- Board meeting, 23/11/2016
- Accounting effect, 15/02/2017
- Power of attorney, Jay Green, Denis Dubru, Michel Nevens, Jerry Stofferis, Anne-Laure Castel, Isabelle Janssens, Carine Abras, Déborah Puttemans
- Power of attorney, Alain Goossens ou Frank Vandewal conjointement avec Valérie Snauwaert ou Christelle Flamme
- Power of attorney, Jay Green, Denis Dubru, Anne-Laure Castel, Isabelle Janssens, Carine Abras
- Power of attorney, Michel Nevens, Jerry Stofferis ou Deborah Puttemans conjointement avec Jay Green, Denis Dubru, Anne-Laure Castel ou Carine Abras
- Power of attorney, Jay Green, Denis Dubru, Anne-Laure Castel, Carine Abras, Michel Nevens, Jerry Stofferis, Isabelle Janssens
- Power of attorney, Deux administrateurs
- Power of attorney, Denis Dubru, Michel Nevens, Jerry Stofferis, Anne-Laure Castel, Isabelle Janssens
- Power of attorney, Denis Dubru, Pascal Reyntjens, Michel Nevens, Jerry Stofferis, Christophe Bertholet, Jonathan Collin, Anne-Laure Castel, Isabelle Janssens
- Power of attorney, Jay Green, Denis Dubru, Alain Goossens, Frank Vandewal, Anne-Laure Castel, Isabelle Janssens
- Power of attorney, Jay Green
- +10 further facts in this act
2016
16-09
State Gazette act
MiscellaneousPower of attorney · Rectification4 facts ▸
State Gazette act
Miscellaneous
Power of attorney · Rectification4 facts ▸
- Board meeting, 28/04/2016
- Power of attorney
- Power of attorney
- Rectification, 24/08/2016
24-08
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 28/04/2016
- Power of attorney, GlaxoSmithKline Biologicals
24-08
State Gazette act
Resignation: Thibaud Stoll (director)Reappointments: Patrick Florent, Gunther Koch and 6 others · Appointments: Russell Edward Thirsk (director) and PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation16 facts ▸
State Gazette act
Resignation: Thibaud Stoll (director)
Reappointments: Patrick Florent, Gunther Koch and 6 others · Appointments: Russell Edward Thirsk (director) and PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Mandate compensation16 facts ▸
- General meeting, 20/07/2016
- Director resignation, Thibaud Stoll (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Luc Debruyne (director)
- Director reappointment, Jay Green (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Jamila Louahed (director)
- Director appointment, Russell Edward Thirsk (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- +4 further facts in this act
30-03
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 10/12/2015
- Power of attorney, Various directors and employees listed in the act
2015
18-08
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 23/04/2015
- Power of attorney, Various employees/managers as detailed in the act
13-07
State Gazette act
Resignation: Vincent Brichard (director)Reappointments: Patrick Florent, Gunther Koch and 6 others · Appointments: Jamila Louahed (director) and PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Romain Seffer and Didier Delanoye16 facts ▸
State Gazette act
Resignation: Vincent Brichard (director)
Reappointments: Patrick Florent, Gunther Koch and 6 others · Appointments: Jamila Louahed (director) and PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Romain Seffer and Didier Delanoye16 facts ▸
- General meeting, 24/06/2015
- Director resignation, Vincent Brichard (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Thibaud Stoll (director)
- Director reappointment, Luc Debruyne (director)
- Director reappointment, Jay Green (director)
- Director reappointment, Denis Dubru (director)
- Director appointment, Jamila Louahed (director)
- Mandate compensation, GlaxoSmithKline Biologicals
- +4 further facts in this act
18-03
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Capital · Statutes amendment4 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment4 facts ▸
- General meeting, 03/03/2015
- Capital increase, €2.453.016.834
- Capital, €9.776.066.380,82
- Statutes amendment
2014
21-08
State Gazette act
Resignation: Christophe Weber (director)Reappointments: Patrick Florent, Thomas Breuer and 7 others · Appointments: Luc Debruyne, Jay Green and John McGrath · Permanent representatives: Emmanuele Attout and Romain Seffer30 facts ▸
State Gazette act
Resignation: Christophe Weber (director)
Reappointments: Patrick Florent, Thomas Breuer and 7 others · Appointments: Luc Debruyne, Jay Green and John McGrath · Permanent representatives: Emmanuele Attout and Romain Seffer30 facts ▸
- General meeting, 25/06/2014
- Director resignation, Christophe Weber (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Thibaud Stoll (director)
- Director reappointment, Vincent Brichard (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, An Vermeersch (director)
- Director appointment, Luc Debruyne (director)
- +18 further facts in this act
08-04
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 12/12/2013
- Power of attorney, multiple persons as listed
2013
19-12
State Gazette act
Resignations & appointmentsPower of attorney28 facts ▸
State Gazette act
Resignations & appointments
Power of attorney28 facts ▸
- Board meeting, 29/05/2013
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- +16 further facts in this act
19-07
State Gazette act
Resignation: Anne-Françoise Nesmes (director)Reappointments: Patrick Florent, Thomas Breuer and 7 others · Appointment: Christophe Weber (director) · Mandate compensation15 facts ▸
State Gazette act
Resignation: Anne-Françoise Nesmes (director)
Reappointments: Patrick Florent, Thomas Breuer and 7 others · Appointment: Christophe Weber (director) · Mandate compensation15 facts ▸
- General meeting, 26/06/2013
- Director resignation, Anne-Françoise Nesmes (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Antoon Loomans (director)
- Director reappointment, Thibaud Stoll (director)
- Director reappointment, Vincent Brichard (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, An Vermeersch (director)
- Director appointment, Christophe Weber (director)
- +3 further facts in this act
28-02
State Gazette act
Resignations & appointmentsPower of attorney13 facts ▸
State Gazette act
Resignations & appointments
Power of attorney13 facts ▸
- Board meeting, 03/12/2012
- Power of attorney, various directors and employees
- Power of attorney, Denis Dubru, Anne-Françoise Nesmes, Anne-Laure Castel, Natalia Davydova, Isabelle Janssens, Alain Goossens, Geert Gepts, Valérie Snauwaert, Christelle Flamme, Michel Nevens, Marie Berranger, Laurence Guiot, Christophe Weber, Antoon Loomans
- Power of attorney, Annie Claus, Valérie Snappe, Sandrine Kehler, Patricia Callewaert, Alain Vanhoolant, Jean-Philippe Dubuisson, Mathieu Haspeslagh, Bénédicte de Moreau d'Andoy, Inma Lafuente, Laurence Colen, Marylène Lombardi, Sylvie Wuillaume, Anne Hoefler, Catherine Stoller, Florence Deroche, Damien Muilier, Emmanuel Mortgat, Jean-Paul Godefroid, Emmanuel Augustin, Freddy Pellichero, Sean McAllister, Xavier Derouck, Adrien Villard, Riantsoa Rasolonjatovo, Maud Defer, Anne Coia, Pascal Reyntjens, Frédéric Stagnitto, Laurent Chevallier, Frédéric Adriaens, Edouard Masurel, Stéphane Masseran, Marcel Laubacher, Thi Minh Tran, Audrey Delbarre, Delphine Michelet, Philippe Maelcamp, Bertrand Masselin, Torben Kring, Stéphane Guironnet, Brice Bouffard
- Power of attorney, Catherine Ghislain, Anne-Françoise Nesmes, Loren Cooper, Claude Copin, Anne-Laure Castel, Annick D'Hont, Antoon Loomans, Denis Dubru, Christophe Weber, Patrick Florent, Emmanuel Hanon, Thibaud Stoll, Giovanni Novello, Benoît Schmits, Philippe Sauvage, Danielle Caucheteux, Pierre Hauser, Pascal Lizin
- Power of attorney, Gunther Koch, Anne-Françoise Nesmes, Christophe Weber, Pierre Braconnier, Hugues Berlemont, Marc Dresse, Véronique Roedolf, Alain Goossens, Geert Gepts, Nathalie Houssein, Antoon Loomans, Catherine Ghislain
- Power of attorney, Denis Dubru, Patrick Florent, Thomas Breuer, Anne-Françoise Nesmes, Antoon Loomans, Christophe Weber, Mauro Bernuzzi, Martine Laumen, Muriel Balthazar, Patricia Pardon, Sonia Gagnon, Laurence Guiot, Marie Berranger, Roberto Fabris, Sébastien Wins, Jean-Philippe Vigneul, Christian George, Apostolos Mamakis, Benjamin Decaluwe, Pierre Legast, Sébastien Odronneau, Eunice Miranda, Stéphane Martin, Bertrand Alexandre, Frederico Vigano, Leanne Hobbs, Anjana Narain, Carel Featherston, Wim Tiest, Christian Courtois, Anthony Blanc, Loren Cooper, Esthel Van Brackel, Lisa Bonadonna, Sian Clayden, Anne Walsh, Vincent Brichard, Anne-Marie Hamoir, Els Hauspie
- Power of attorney, Christophe Weber, Antoon Loomans, Emmanuel Hanon, Vincent Brichard, Thomas Breuer, Anne-Françoise Nesmes, Catherine Ghislain, Loren Cooper
- Power of attorney, Emmanuel Hanon, Vincent Brichard, Christophe Weber, Sandra Giannini, Ventzislav Vassilev, Christiane Feron, Michaël Minet, Sylvie Cayphas, Sally Mossman, Philippe Denoel, Gérald Voss, Marcelle Van Mechelen, Michel Coste, Koenraad De Heyder, Laurent Pierard, Isabelle Knott, Benoît Champluvier, Dominique Lemoine, Philippe Dehottay, Olivier Laloux, Jean-Philippe Lièvremont, Patrick Chomez, Pierre Hauser, Stéphane Veenstra, Jamila Louahed, Rémi Palmantier, Wim Tiest, Pascal Mettens, André Graindorge, Jean Smal, Catherine Ghislain, Loren Cooper, Antoon Loomans, Isabelle Parent, Philippe Hoebregts, Françoise Fievet
- Power of attorney, Musa Ghannam, Anne-Françoise Macq, Paul Nelis, Clive Blatchford, André Graindorge, Stephan Peeters, Vincent Dubois
- Power of attorney, Carine Claeys, Serge Debrus, Antonio Olivieri, Laurence de Moerlooze, Maarten Leyssen, Frank Struyf, Paul Gillard, Kurt Dobbelaere, Dorota Borys, Wim Tiest, Jeanne-Marie Devaster, Dominique Boutriau, Amanda Leach, Patrick Therasse, Frédéric Lehmann, Eric Dusseux, Lidia Oostvogels, Patricia Izurieta, Florence Wastelin, Norman Begg, Alain Brecx, Didier Lapierre, Francesca Ceddia, Ripley Ballou, Marie-Thérèse Martin, Sophie Biernaux, Martine Wettendorff, William Hausdorff, Thomas Breuer, Vincent Brichard, Christophe Weber, Baudouin Standaert, Nadia Meyer, Laurence Baril, Romulo Colindres, Vivek Shinde, Felix Arellano, Lode Schuerman, Nathalie Garçon, Anil Dutta, Jens Renstrup, François Meurice, Jane Zeller, Dirk Campens, Michael Zaiac, Su-Peing Ng, Tatjana Poplazarova, Virginie Hamtiaux, Hilde Van Der Schueren, Véronique Brulein, Alex Lancksweert, François Beckers, Peter Collins, Eddy Reilly, Michel Zaiac, Anne-Marie Rime, Eric Sariet
- Power of attorney, Catherine Ghislain, Loren Cooper, Antoon Loomans
- +1 further facts in this act
2012
09-10
State Gazette act
Resignations & appointmentsPower of attorney12 facts ▸
State Gazette act
Resignations & appointments
Power of attorney12 facts ▸
- Board meeting, 29/08/2012
- Power of attorney, Denis Dubru
- Power of attorney, Anne-Françoise Nesmes
- Power of attorney, Anne-Laure Castel
- Power of attorney, Natalia Davydova
- Power of attorney, Isabelle Janssens
- Power of attorney, Alain Goossens
- Power of attorney, Geert Gepts
- Power of attorney, Valérie Snauwaert
- Power of attorney, Christelle Flamme
- Power of attorney, Christophe Weber
- Power of attorney, Antoon Loomans
18-07
State Gazette act
Resignation: Jean Stéphenne (director)Reappointments: Patrick Florent, Thomas Breuer and 4 others · Appointments: Antoon Loomans, Thibaud Stoll and 4 others · Permanent representative: Emmanuele Attout16 facts ▸
State Gazette act
Resignation: Jean Stéphenne (director)
Reappointments: Patrick Florent, Thomas Breuer and 4 others · Appointments: Antoon Loomans, Thibaud Stoll and 4 others · Permanent representative: Emmanuele Attout16 facts ▸
- General meeting, 27/06/2012
- Director resignation, Jean Stéphenne (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Anne-Françoise Nesmes (director)
- Director appointment, Antoon Loomans (director)
- Director appointment, Thibaud Stoll (director)
- Director appointment, Vincent Brichard (director)
- Director appointment, Ann Vermeersch (director)
- +4 further facts in this act
20-06
State Gazette act
Resignations & appointmentsPower of attorney8 facts ▸
State Gazette act
Resignations & appointments
Power of attorney8 facts ▸
- Board meeting, 23/04/2012
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
22-03
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 05/12/2011
- Power of attorney, Mandataires désignés (liste complète dans l'acte)
2011
08-12
State Gazette act
Resignations: Jean-Paul Priets (director) and Jean-Pierre Suin (director)Reappointments: Jean Stéphenne, Patrick Florent and 5 others · Appointment: Christophe Weber (director) · Mandate compensation12 facts ▸
State Gazette act
Resignations: Jean-Paul Priets (director) and Jean-Pierre Suin (director)
Reappointments: Jean Stéphenne, Patrick Florent and 5 others · Appointment: Christophe Weber (director) · Mandate compensation12 facts ▸
- General meeting, 22/06/2011
- Director resignation, Jean-Paul Priets (director)
- Director resignation, Jean-Pierre Suin (director)
- Director reappointment, Jean Stéphenne (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Anne-Françoise Nesmes (director)
- Director appointment, Christophe Weber (director)
- Mandate compensation, GlaxoSmithKline Biologicals
14-09
State Gazette act
Resignations: Jean-Paul Prieels (director) and Jean-Pierre Suin (director)Reappointments: Jean Stéphenne, Patrick Florent and 5 others · Appointment: Christophe Weber (director) · Mandate compensation12 facts ▸
State Gazette act
Resignations: Jean-Paul Prieels (director) and Jean-Pierre Suin (director)
Reappointments: Jean Stéphenne, Patrick Florent and 5 others · Appointment: Christophe Weber (director) · Mandate compensation12 facts ▸
- General meeting, 24/06/2011
- Director resignation, Jean-Paul Prieels (director)
- Director resignation, Jean-Pierre Suin (director)
- Director reappointment, Jean Stéphenne (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Gunther Koch (director)
- Director reappointment, Emmanuel Hanon (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Anne-Françoise Nesmes (director)
- Director appointment, Christophe Weber (director)
- Mandate compensation, GlaxoSmithKline Biologicals
18-08
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
State Gazette act
Resignations & appointments
Power of attorney2 facts ▸
- Board meeting, 26/04/2011
- Power of attorney, Arithmos
21-03
State Gazette act
Resignations & appointmentsPower of attorney12 facts ▸
State Gazette act
Resignations & appointments
Power of attorney12 facts ▸
- Board meeting, 16/12/2010
- Power of attorney, Denis Dubru
- Power of attorney, Anne-Françoise Nesmes
- Power of attorney, Anne-Laure Castel
- Power of attorney, Natalia Davydova
- Power of attorney, Isabelle Janssens
- Power of attorney, Thierry Lancelot
- Power of attorney, Alain Goossens
- Power of attorney, Valérie Snauwaert
- Power of attorney, Christelle Flamme
- Power of attorney, Antoon Loomans
- Power of attorney, Jean Stéphenne
14-03
State Gazette act
Capital & shares · Statutes amendmentShare cancellation · Capital · Statutes amendment8 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Share cancellation · Capital · Statutes amendment8 facts ▸
- General meeting, 27 décembre 2010
- Share cancellation, annulation des actions propres acquises
- Capital, €7.323.049.546,82
- Statutes amendment, 5
- Statutes amendment, 5bis
- Statutes amendment, 10
- Statutes amendment, 40
- Share buyback, rachat d'actions propres
2010
04-11
State Gazette act
Resignations & appointmentsPower of attorney9 facts ▸
State Gazette act
Resignations & appointments
Power of attorney9 facts ▸
- Board meeting, 30-04-2010
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
- Power of attorney
12-10
State Gazette act
Resignations: Philippe Monteyne (director) and Luc Vanden Broeck (director)Reappointments: Jean Stéphenne, Jean-Pierre Suin and 5 others · Appointments: Gunther Koch (director) and Emmanuel Hanori (director) · Mandate compensation13 facts ▸
State Gazette act
Resignations: Philippe Monteyne (director) and Luc Vanden Broeck (director)
Reappointments: Jean Stéphenne, Jean-Pierre Suin and 5 others · Appointments: Gunther Koch (director) and Emmanuel Hanori (director) · Mandate compensation13 facts ▸
- General meeting, 23/06/2010
- Director resignation, Philippe Monteyne (director)
- Director resignation, Luc Vanden Broeck (director)
- Director reappointment, Jean Stéphenne (director)
- Director reappointment, Jean-Pierre Suin (director)
- Director reappointment, Jean-Paul Prieels (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Thomas Breuer (director)
- Director reappointment, Denis Dubru (director)
- Director reappointment, Anne-Françoise Nesmes (director)
- Director appointment, Gunther Koch (director)
- Director appointment, Emmanuel Hanori (director)
- +1 further facts in this act
27-05
State Gazette act
Resignations & appointmentsPower of attorney13 facts ▸
State Gazette act
Resignations & appointments
Power of attorney13 facts ▸
- Board meeting, 17/12/2009
- Board resolution, Modification et remplacement des paragraphes 1, 2, 3, 4 et 11 des pouvoirs arrêtés le 18 avril 2008, modifiés le 23.10.2008 et le 26.01.2009, concernant les mat…
- Power of attorney, Denis Dubru
- Power of attorney, Jean-Pierre Suin
- Power of attorney, Anne-Françoise Nesmes
- Power of attorney, Pierre Braconnier
- Power of attorney, Jean Stéphenne
- Power of attorney, Luc Vanden Broeck
- Power of attorney, A. Rappagliosi
- Power of attorney, Géraldine Joulin
- Power of attorney, Chris Strutt
- Power of attorney, Marcel Laubacher
- +1 further facts in this act
10-02
State Gazette act
Appointments: A. Rappagliosi (daily management delegate) and Géraldine Joulin (daily management delegate)2 facts ▸
State Gazette act
Appointments: A. Rappagliosi (daily management delegate) and Géraldine Joulin (daily management delegate)
2 facts ▸
- Director appointment, A. Rappagliosi (daily management delegate)
- Director appointment, Géraldine Joulin (daily management delegate)
2009
21-09
State Gazette act
Resignations: Jean Stéphenne, Jean-Pierre Suin and 4 othersReappointments: Jean Stéphenne, Jean-Pierre Suin and 3 others · Appointments: Thomas Breuer, Philippe Monteyne and 3 others · Mandate compensation18 facts ▸
State Gazette act
Resignations: Jean Stéphenne, Jean-Pierre Suin and 4 others
Reappointments: Jean Stéphenne, Jean-Pierre Suin and 3 others · Appointments: Thomas Breuer, Philippe Monteyne and 3 others · Mandate compensation18 facts ▸
- General meeting, 24/06/2009
- Director resignation, Jean Stéphenne (director)
- Director resignation, Jean-Pierre Suin (director)
- Director resignation, Jean-Paul Prieels (director)
- Director resignation, Patrick Florent (director)
- Director resignation, Denis Dubru (director)
- Director reappointment, Jean Stéphenne (director)
- Director reappointment, Jean-Pierre Suin (director)
- Director reappointment, Jean-Paul Prieels (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Denis Dubru (director)
- Director appointment, Thomas Breuer (director)
- +6 further facts in this act
2008
28-01
State Gazette act
Resignations & appointmentsPower of attorney35 facts ▸
State Gazette act
Resignations & appointments
Power of attorney35 facts ▸
- Board meeting, 29/03/2007
- Board meeting, 27/09/2007
- Power of attorney, Jean Stéphenne
- Power of attorney, David Stout
- Power of attorney, Fabrice Enderlin
- Power of attorney, Pierre Braconnier
- Power of attorney, Gunther Koch
- Power of attorney, Hazel Chapman
- Power of attorney, Jean-Pierre Suin
- Power of attorney, Denis Dubru
- Power of attorney, Eric Vanderpoorten
- Power of attorney, Hugues Bertemont
- +23 further facts in this act
2006
13-03
State Gazette act
Capital & shares · RestructuringMerger · Accounting effect · Capital increase10 facts ▸
State Gazette act
Capital & shares · Restructuring
Merger · Accounting effect · Capital increase10 facts ▸
- General meeting, 30/12/2005
- Merger, 23:45, 31/12/2005
- Accounting effect, 30/12/2005
- Capital increase, €206.078.515,1
- Capital, €7.323.049.546,82
- Share cancellation, Les actions numérotées de 1 à 53.629 (actions de catégorie A), et les actions numérotées de 316.443 à 2.681 450 (actions de catégorie B), ont été annulées.
- Statutes amendment
- Statutes amendment
- Exchange ratio, 0,07241959 action de la S.A. GlaxoSmithKline Biologicals contre 1 droit social de EUR 100 de la S.N.C GlaxoSmithKline Biologicals Services
- Auditor report, 23/12/2005
2004
07-10
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Capital · Statutes amendment8 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment8 facts ▸
- General meeting, 23 juin 2004
- Capital increase, €70.206.225,91
- Capital, €7.116.971.031,72
- Statutes amendment
- Statutes amendment
- Net-asset statement, 31 décembre 2003
- Accounting effect, 1er janvier 2004
- Share cancellation, 1 à 53 629, 316 443 à 2 681 450
23-02
State Gazette act
Capital & shares · Statutes amendment · RestructuringCapital increase · Merger · Capital8 facts ▸
State Gazette act
Capital & shares · Statutes amendment · Restructuring
Capital increase · Merger · Capital8 facts ▸
- General meeting, 22 décembre 2003
- Capital increase, €151.024
- Merger, fusion par absorption, 01/01/2004
- Capital increase, €247,91
- Capital, €7.046.764.805,81
- Share cancellation, Les actions numérotées de 1 à 53.629 (actions de catégorie A), et les actions numérotées de 316.443 à 2.681.450 (actions de catégorie B), ont été annulées
- Statutes amendment
- Auditor report, commissaire / Réviseur d'Entreprises, 20 novembre 2003
2003
15-12
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Share issue · Capital8 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Capital increase · Share issue · Capital8 facts ▸
- General meeting, 2 octobre 2003
- Capital increase, €46.582.801,64
- Share issue, nouvelles actions nominatives ... sans désignation de valeur nominale
- Capital increase, €99.271.571,26
- Capital, €7.046.613.533,9
- Statutes amendment
- Share cancellation, actions de catégorie A numérotées de 1 à 53.629 et actions de catégorie B numérotées de 316.443 à 2.681.450
- Contribution in kind, 394.970 actions
02-10
State Gazette act
Resignations & appointmentsPower of attorney25 facts ▸
State Gazette act
Resignations & appointments
Power of attorney25 facts ▸
- Board meeting, 22/05/2003
- Power of attorney, Bernard Adam
- Power of attorney, William Ripley Ballou
- Power of attorney, Hans Bock
- Power of attorney, Hugues Bogaerts
- Power of attorney, Luigs Bonfatti
- Power of attorney, Dominique Boutriau
- Power of attorney, Antony Braithwaite
- Power of attorney, Thomas Breuer
- Power of attorney, Vincent Brichard
- Power of attorney, Thérèse Braems
- Power of attorney, Claudine Bruck
- +13 further facts in this act
29-09
State Gazette act
Resignations: Jean-Luc Bocken (director) and Moncif Slaoui (director)Reappointments: Jean Stéphenne, Jean-Paul Prieels and 3 others · Appointments: Fabrice Enderlin (director) and Denis Dubru (director) · Mandate compensation11 facts ▸
State Gazette act
Resignations: Jean-Luc Bocken (director) and Moncif Slaoui (director)
Reappointments: Jean Stéphenne, Jean-Paul Prieels and 3 others · Appointments: Fabrice Enderlin (director) and Denis Dubru (director) · Mandate compensation11 facts ▸
- General meeting, 25/06/2003
- Director resignation, Jean-Luc Bocken (director)
- Director resignation, Moncif Slaoui (director)
- Director reappointment, Jean Stéphenne (director)
- Director reappointment, Jean-Paul Prieels (director)
- Director reappointment, Jean-Pierre Suin (director)
- Director reappointment, Patrick Florent (director)
- Director reappointment, Johan Van Hoof (director)
- Director appointment, Fabrice Enderlin (director)
- Director appointment, Denis Dubru (director)
- Mandate compensation, GlaxoSmithKline Biologicals
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
27 directors, no change since 2026
D. Descamps
CurrentDirector · since 02-04-2026
C. Noirhomme
CurrentDirector · since 03-09-2025
Christelle Noirhomme
CurrentDirector · since 03-09-2025
Jamila Louahed
CurrentManaging director · since 03-09-2025
Emmanuel FELIX
CurrentManaging director · since 25-06-2025
Cristelle Noirhomme
CurrentDirector · since 23-02-2022
21 other directors
Philippe Denoel
CurrentDirector · since 23-02-2022
A. Van Goethem
CurrentDirector
B. Alsteens
CurrentDirector
E. Felix
CurrentDirector
I. Rapilly
CurrentDirector
P. Legraive
CurrentDirector
R. Simard
CurrentDirector
Emmanuel Hanon
Not recently confirmedDirector · since 22-06-2011
Denis Dubru
Not recently confirmedDirector · since 23-06-2010
Russell Edward Thirsk
Not recently confirmedDirector · since 20-07-2016
William Dawson
Not recently confirmedDirector · since 28-06-2017
Russell Thirsk
Not recently confirmedDirector · since 28-06-2017
An Vermeersch
Not recently confirmedDirector · since 26-06-2013
John McGrath
Not recently confirmedDirector · since 25-06-2014
Thomas Breuer
Not recently confirmedDirector · since 24-06-2009
Ann Vermeersch
Not recently confirmedDirector · since 27-06-2012
Emmanuel Hanori
Not recently confirmedDirector · since 23-06-2010
A. Rappagliosi
Not recently confirmedDaily management delegate · since 15-06-2009
Géraldine Joulin
Not recently confirmedDaily management delegate · since 15-06-2009
Fabrice Enderlin
Not recently confirmedDirector · since 29-09-2003
Johan Van Hoof
Not recently confirmedDirector
02-04-2026
D. Descamps: Appointed as Director
31-03-2026
J. Louahed: Resigned as Director
03-09-2025
C. Noirhomme: Appointed as Director
03-09-2025
Christelle Noirhomme: Appointed as Director
03-09-2025
Jamila Louahed: Reappointed as Director
Location & real-estate footprint
Registered office, Rixensart · 5 establishment units since 1990
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de l'Institut 891330 RixensartGround area
48.6 ha
Building footprint
8,314 m²
Volume, LiDAR
120,633 m³
4 parcels, Brussels, Wallonia · tallest building 32.8 m, ±10 floors. Linked by address, not a title deed.
5 establishment units
GLAXOSMITHKLINE BIOLOGICALS
since 19902.049.062.048
GLAXOSMITHKLINE BIOLOGICALS
since 20052.151.097.239
GLAXOSMITHKLINE BIOLOGICALS
since 20052.151.097.734
GLAXOSMITHKLINE BIOLOGICALS
since 20072.160.129.127
GLAXOSMITHKLINE BIOLOGICALS
since 20152.263.209.740
4 parcels
Wallonia
3
(75%)
Brussels
1
(25%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112C0097/00P000 | Wallonia | 30.5 ha | 1 · 4,249 m² | 24.5 m · 7 fl. |
| 25091G0001/00B002 | Wallonia | 16.7 ha | 1 · 2,458 m² | - |
| 25112C0020/00N000 | Wallonia | 1.3 ha | 1 · 891 m² | 14.6 m · 4 fl. |
| 21805E0345/00C000 | Brussels | 716 m² | 1 · 716 m² | 32.8 m · 10 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 3
4 of 4 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
1 auditor| Deloitte Réviseurs d'EntreprisesCurrent Statutory auditor · represented by Koen Neijens | 01-08-2018 → present |
Show 2 earlier auditors
| Michel Lange Statutory auditor succeeded by PricewaterhouseCoopers Réviseurs d'entreprises in 2012 | 21-09-2009 → 18-07-2012 |
| PricewaterhouseCoopers Réviseurs d'entreprises Statutory auditor succeeded by Deloitte Réviseurs d'Entreprises in 2018 | 18-07-2012 → 01-08-2018 |
Structure & network
Connections & network
25 connected companiesLinked via shared directors
via Cristelle Noirhomme · Director
→
via Emmanuel FELIX · Director
former→
via Emmanuel FELIX · Director
former→
via Cristelle Noirhomme · Director
former→
Show 21 more companies with a shared director
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Ownership & control
1 parent company · 1 board mandateControl over this companyparent company per the LEI register1
GSK PLC
London, United Kingdom
controls
GlaxoSmithKline BiologicalsBE 0440.872.918
Board mandates of this companythis company sits on their board1
Acquisitions and mergers
2 transactionsTook over:GlaxoSmithKline Biologicals Services
Took over:GlaxoSmithKline Biologicals Biotech
Capital and shareholders
Capital over the years
- 24-12-2021 Capital reduction of 5,100,000,000 EUR · to 8,379,632,620.82 EUR · repaid to the shareholders
- 14-02-2020 Capital increase of 3,703,566,240 EUR · to 13,479,632,620.82 EUR · from reserves
- 18-03-2015 Capital increase of 2,453,016,834 EUR · to 9,776,066,380.82 EUR
- 14-03-2011 Capital stated in the act · 7,323,049,546.82 EUR · 9,009,226 shares
- 13-03-2006 Capital increase of 206,078,515.10 EUR · to 7,323,049,546.82 EUR · 149,241 new shares
- 07-10-2004 Capital increase of 70,206,225.91 EUR · to 7,116,971,031.72 EUR · from reserves
- 23-02-2004 Capital increase of 151,024 EUR · to 7,046,764,557.90 EUR · in kind
- 23-02-2004 Capital increase of 247.91 EUR · to 7,046,764,805.81 EUR · fusion par absorption
Show 2 older capital entries
- 15-12-2003 Capital increase of 46,582,801.64 EUR · to 6,947,341,962.64 EUR · in kind
- 15-12-2003 Capital increase of 99,271,571.26 EUR · to 7,046,613,533.90 EUR · from reserves
Public money · subsidies and aid
European research
26 projects · 4 as coordinator · 15,159,399 EUR EU contributionProgrammes
Horizon 2020
Seventh Framework Programme
Horizon Europe
Projects
Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine
Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes
System for Immunological Modelling as an Ultimate tool to Link Adjuvant function To Adaptive immune responses
Exploring the roles and plasticity of T-cell responses in anti-BACterial immunity
Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses
Show 21 more projects
Discovery and preclinical development of new generation tuberculosis vaccines
A Multi-Stage Malaria Vaccine
Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes
The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease
Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
Innovations to accelerate vaccine development and manufacture
Preparing for RSV Immunisation and Surveillance in Europe
Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance
PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910
Vaccine lot to Vaccine lot comparison by consistency testing.
REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019
TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections
Development of Robust and Innovative Vaccine Effectiveness
Vaccines and Infectious Diseases in the Ageing PopuLation
Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa
Biomarkers For Enhanced Vaccine Safety
Accelerated Development of Vaccine benefit-risk Collaboration in Europe
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection
Advanced Immunization Technologies
Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens
Recognitions · licences · registrations
Food safety, FASFC
3 sites · 2 with a smileyRixensart2.049.062.048
Wavre2.151.097.239
Wavre2.160.129.127
Legal Entity Identifier
5493004ZNHN6CAC59L18
Similar companies · same sector, comparable size
Janssen Pharmaceutica
BE 0403.834.160
Beerse · Eq €10.46B
UCB PHARMA
BE 0403.096.168
Anderlecht · Eq €16.23B
UCB BIOPHARMA
BE 0543.573.053
Anderlecht · Eq €1.18B
PFIZER MANUFACTURING BELGIUM
BE 0400.778.165
Puurs-Sint-Amands · Eq €1.01B
Of 148 companies in sector 21201 we hold annual accounts for 116. 4 are within a factor 10 of this equity. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded01-07-1990
Fiscal year end31-12
Abbreviation FR
GSK Biologicals - SmithKline Beecham Biologicals
Activities, NACEBEL 2025
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sources
Crossroads Bank for EnterprisesNational Bank · 41 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesPhone:02/6568111
Fax:02/6568000